Zacks Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,949
Closed -$1.46M 611
2021
Q2
$1.46M Sell
15,949
-24,191
-60% -$1.92M 0.02% 321
2021
Q1
$2.73M Sell
40,140
-4,379
-10% -$340K 0.05% 237
2020
Q4
$3.23M Sell
44,519
-2,687
-6% -$156K 0.06% 198
2020
Q3
$1.79M Sell
47,206
-3,263
-6% -$110K 0.04% 239
2020
Q2
$1.79M Sell
50,469
-4,811
-9% -$137K 0.04% 217
2020
Q1
$1.21M Sell
55,280
-2,219
-4% -$49.7K 0.03% 271
2019
Q4
$1.24M Buy
+57,499
New +$1.32M 0.02% 356

Other funds holding CDNA

Zacks Investment Management's CDNA Position: Q3 2021 in Review

Zacks Investment Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 15,949 shares — an estimated $1.46M sold.

Zacks Investment Management first reported a position in CDNA in Q4 2019 and held it in 7 quarters. The position peaked at $3.23M in Q4 2020. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Zacks Investment Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Zacks Investment Management sold 15,949 CareDx shares in Q3 2021, an estimated $1.46M.
  • Zacks Investment Management first reported a position in CareDx in Q4 2019 and held it in 7 quarters.
  • Zacks Investment Management's CareDx position peaked at $3.23M in Q4 2020.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Zacks Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.